The case for investing in fusion energy has never been greater, given increasing global energy demand, high annual carbon dioxide output, and technological limitations for wind and solar power. Nevertheless, financing for fusion companies through traditional means has proven challenging.
- US DOE Milestone Program
- CFS Selected by US DOE
- Lawrence Livermore National Laboratory Achieves Fusion Ignition
- BlackRock and QLS Advisors Partner Through BlackRock Systematic to Invest in Biomedical Innovation
- BIO, QLS, and Informa Pharma Intelligence have released a new report on clinical development success rates covering 2011-2020